Treatment decisions and the impact of adverse events before and during extended endocrine therapy in postmenopausal early breast cancer
Author:
Funder
Novartis
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference16 articles.
1. Extended adjuvant endocrine therapy in hormone-receptor positive early breast cancer: Current and future evidence;Blok;Cancer Treat Rev,2015
2. Extended adjuvant endocrine therapy in early breast cancer: a meta-analysis of published randomized trials;Ibrahim;Med Oncol,2017
3. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer;Goss;N Engl J Med,2003
4. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial;Davies;Lancet,2013
5. aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer;Gray;J Clin Oncol,2013
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impact of the Breast Cancer Index for Extended Endocrine Decision-Making: First Results of the Prospective BCI Registry Study;Journal of the National Comprehensive Cancer Network;2024-03
2. Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study;European Journal of Cancer;2023-05
3. Influence of Glutathione-S-Transferase A1*B Allele on the Metabolism of the Aromatase Inhibitor, Exemestane, in Human Liver Cytosols and in Patients Treated With Exemestane;Journal of Pharmacology and Experimental Therapeutics;2022-07-06
4. Women with breast cancer’s perceptions of nurse-led telephone-based motivational interviewing consultations to enhance adherence to adjuvant endocrine therapy: a qualitative study;Supportive Care in Cancer;2022-02-08
5. Primary care and preventable hospitalizations among Medicare beneficiaries with non-metastatic breast cancer;Journal of Cancer Survivorship;2022-01-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3